XXXX -Induced Psychosis.

@entity1 @entity15093 @entity2682 @entity1092 @entity5774 @entity33019 @entity1011 @entity1089
BACKGROUND: @entity33019 ( @entity15093 ) is a 5-hydroxytryptamine 2A and 1A receptor agonist that exhibits potent psychoactive properties in @entity1 . Recreational use of this drug has increased precipitously and is likely to result in an increase in @entity1 presenting with substance-induced psychoses. The present case provides an early example of substance-induced psychosis attributable to repeated use of @entity15093 . CASE: A 42-year-old white @entity1 , with no significant past psychiatric history, was brought to the emergency department by the police and was found to exhibit disinhibited behavior, elevated affect, disorganized thought process, and delusions of reference. Laboratory studies revealed elevated @entity1011 kinase level indicative of rhabdomyolysis. The @entity1 endorsed recent and repeated use of @entity15093 , as well as long-term Cannabis (marijuana) use. Over the course of the next 3 weeks, the @entity1 was successfully treated with @entity1089 for psychosis, @entity1092 (Depakote) for impulsivity, @entity2682 for anxiety, and @entity5774 for sleep, which resulted in the resolution of his symptoms and development of reasonable insight and judgment. Approximately 6 months after discharge, the @entity1 remained treatment compliant, as well as drug and symptom free. CONCLUSIONS: This case report illustrates an important example of substance-induced psychosis that resolved with antipsychotic treatment in a 42-year-old white @entity1 with no past psychiatric history likely attributable to the use of @entity15093 . Given the increasing use of this substance, the emergency department, primary care, and inpatient services are likely to see a significant increase in similar cases.
